Nonetheless, the result of CKPT’s bull case will in all probability be resolved within the close to time period. Given the comparatively brief timeline for the FDA's determination, CKPT may...
Shares of Invivyd (NASDAQ:IVVD) closed 42% increased Friday after the biotech firm introduced it had obtained FDA emergency use authorization, or EUA, for its COVID-19 prophylactic drug Pemgarda and launched Part...